BNP Paribas Knock-Out ABT/ DE000PH781V6 /
2024-11-07 9:50:12 AM | Chg.-0.02 | Bid10:26:12 AM | Ask10:26:12 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.26EUR | -0.61% | 3.26 Bid Size: 7,300 |
3.30 Ask Size: 7,300 |
Abbott Laboratories | 151.4417 USD | 2078-12-31 | Put |
GlobeNewswire
08-06
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06-06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
05-09
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer